• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody

Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody [clone III-19] (RQ5397)

  Catalog No Formulation Size Price (USD)  
Image RQ5397 Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA 100 ul 449
Microvalidated Rab Mono Image
Bulk quote request
Src Antibody III-19 WB Analysis of Human HCT116 WT and SRC KO Cell Lysates. Western blot analysis of human HCT116 wild-type (lane 1) and HCT116 SRC knockout (lane 2) whole-cell lysates using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at a 1:500 dilution. An immunoreactive band is detected at approximately 60 kDa in wild-type cells and is absent from the SRC knockout sample, supporting antibody specificity for SRC. Each lane contains 30 ug of protein. GAPDH is shown as a loading control.
Src Antibody III-19 WB Analysis of Human Cell Lines and Rodent Tissue Lysates. Western blot analysis of human 293T (lane 1), HeLa (lane 2), and K562 (lane 3) whole-cell lysates, rat brain (lane 4), rat spleen (lane 5), and mouse brain (lanes 6-7) tissue lysates using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at a 1:1000 dilution. An immunoreactive band is detected at approximately 60 kDa across the samples, consistent with the calculated molecular weight of SRC (59.8 kDa). Each lane contains 30 ug of protein.
Src Antibody III-19 IHC Staining of Human Stomach Cancer. Immunohistochemical analysis of FFPE human stomach cancer tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 5 ug/ml. Brown DAB immunoreactivity is observed in malignant glandular epithelial structures, with variable staining across the tissue section. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8.
Src Antibody III-19 IHC Staining of Human Liver Cancer. Immunohistochemical analysis of FFPE human liver cancer tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 5 ug/ml. Brown DAB staining is observed throughout portions of the tumor tissue, predominantly within the cytoplasmic regions of malignant cells. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8.
Src Antibody III-19 IHC Staining of Human Colon Cancer. Immunohistochemical analysis of FFPE human colon cancer tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 5 ug/ml. Brown DAB immunoreactivity is observed in malignant glandular epithelial structures. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8, followed by overnight primary antibody incubation at 4oC.
Src Antibody III-19 IHC Staining of Mouse Kidney. Immunohistochemical analysis of FFPE mouse kidney tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 5 ug/ml. Brown DAB immunoreactivity is detected in renal tubular structures, with comparatively limited staining in portions of the surrounding tissue. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8.
Src Antibody III-19 IHC Staining of Rat Testis. Immunohistochemical analysis of FFPE rat testis tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 5 ug/ml. Brown DAB staining is observed within seminiferous tubules, with variable immunoreactivity among the cellular populations. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8.
Src Antibody III-19 IF Staining of Human Stomach Cancer. Immunofluorescence analysis of FFPE human stomach cancer tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 25 ug/ml. Red fluorescence is detected throughout portions of the tumor tissue, with blue DAPI staining identifying cell nuclei. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8. DyLight 594-conjugated goat anti-rabbit IgG was used for detection.
Src Antibody III-19 IF Staining of Human Prostate Cancer. Immunofluorescence analysis of FFPE human prostate cancer tissue using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at 25 ug/ml. Red fluorescence is observed in tumor-associated epithelial structures, with blue DAPI nuclear counterstaining. Heat-induced epitope retrieval was performed using EDTA buffer at pH 8, followed by overnight primary antibody incubation at 4oC. DyLight 594-conjugated goat anti-rabbit IgG was used for detection.
Src Antibody III-19 IF Staining of Human HeLa Cells. Immunofluorescence analysis of human HeLa cells using Proto-Oncogene Tyrosine-Protein Kinase Src Antibody clone III-19 at a 1:50 dilution. SRC-associated fluorescence is shown in green, with red phalloidin-TRITC labeling filamentous actin and blue DAPI counterstaining cell nuclei. The merged image illustrates the distribution of SRC-associated signal relative to the actin cytoskeleton and nuclei.
Species Reactivity Human, Mouse, Rat
Format Purified
Host Rabbit
Clonality Rabbit Monoclonal
Isotype Rabbit IgG
Clone Name III-19
Purity Affinity purified
UniProt P12931
Applications Western blot: 1:1000
Immunohistochemistry (FFPE): 5ug/ml
Immunofluorescence: 25ug/ml
Limitations This Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

  • Applications : WB
    Reactivity : Human, Mouse, Rat
    Recrabbitmono
  • Applications : WB, ICC, IF
    Reactivity : Human, Mouse, Rat
    Recrabbitmono
  • Applications : WB, IF, ELISA
    Reactivity : Human, Mouse
  • Applications : WB
    Reactivity : Human
  • Applications : WB
    Reactivity : Human, Mouse, Rat
    Rab Mono Image
  • Applications : WB, IHC-P, FACS
    Reactivity : Human
  • Applications : WB, ELISA
    Reactivity : Mouse
  • Applications : WB, ELISA
    Reactivity : Human, Mouse, Rat
  • Applications : IHC, IF, WB, ELISA
    Reactivity : Human, Mouse
  • Applications : IHC, IF, WB, ELISA
    Reactivity : Human
    Pred. Reactivity : Mouse, Rat, Bovine, Pig, Chicken, Zebrafish, Xenopus
  • Applications : WB, IHC, FACS, IF, ELISA
    Reactivity : Human
    Pred. Reactivity : Mouse
  • Applications : WB, ELISA
    Reactivity : Human
    Pred. Reactivity : Chicken, Mouse, Rat, Xenopus, Zebrafish
  • Applications : DB, ELISA
    Reactivity : Human
    Pred. Reactivity : Bovine, Chicken, Mouse, Pig, Rat, Xenopus, Zebrafish
  • Applications : DB, IHC, ELISA
    Reactivity : Human
    Pred. Reactivity : Chicken, Mouse, Rat, Zebrafish

Description

Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody targets SRC, a non-receptor tyrosine kinase that regulates signaling pathways involved in cell proliferation, adhesion, migration, differentiation, and survival. Also known as c-Src, SRC is the founding member of the Src family kinases and functions downstream of numerous cell surface receptors, including receptor tyrosine kinases, integrins, and G protein-coupled receptors. Through phosphorylation of specific tyrosine residues, SRC coordinates intracellular responses to extracellular signals and contributes to cytoskeletal organization, cell polarity, and tissue homeostasis.

SRC contains an N-terminal membrane-targeting region, SH3 and SH2 interaction domains, a catalytic SH1 kinase domain, and a C-terminal regulatory tail. N-terminal myristoylation promotes membrane association, positioning SRC near receptor complexes and signaling proteins. Its kinase activity is controlled by intramolecular interactions and regulatory phosphorylation. Phosphorylation of the C-terminal inhibitory tyrosine by C-terminal Src kinase (CSK) stabilizes an inactive conformation, while dephosphorylation and conformational changes facilitate activation. Autophosphorylation within the activation loop further increases catalytic activity. These mechanisms allow SRC to respond rapidly to changes in receptor signaling and cellular adhesion.

Activated SRC interacts with focal adhesion kinase (FAK), paxillin, and other proteins involved in focal adhesion assembly and turnover. These interactions connect integrin signaling to actin cytoskeletal remodeling, cell spreading, and migration. SRC also participates in the RAS-MAPK, PI3K-AKT, and STAT signaling pathways, linking receptor activation to transcriptional regulation, metabolism, and cell survival. Its extensive network of substrates enables SRC to integrate growth factor signaling with mechanical and adhesive cues, influencing epithelial organization, developmental processes, and cellular responses to environmental changes.

Dysregulated SRC activity has been implicated in tumor development and progression, particularly through its effects on proliferation, invasion, migration, and resistance to apoptosis. Elevated SRC signaling has been investigated in colorectal, breast, lung, and other malignancies, where it can cooperate with growth factor receptors and oncogenic pathways. SRC also contributes to normal tissue remodeling and cellular communication, making its regulation important beyond cancer biology. Src Antibody III-19 supports research into SRC expression, kinase-associated signaling networks, and the molecular mechanisms connecting cellular adhesion, growth regulation, and malignant progression.

SRC is a central regulator of growth factor signaling, integrin-mediated adhesion, and cellular migration, making it an important target in signal transduction research.

Application Notes

Optimal dilution of the Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody should be determined by the researcher.

Immunogen

A synthetic peptide specific to human Src was used as the immunogen for the Src antibody.

Storage

Store the Src antibody at -20oC.

Alternate Names

c-Src antibody, SRC antibody, Proto-oncogene c-Src antibody, Tyrosine-protein kinase Src antibody, Proto-oncogene tyrosine-protein kinase Src antibody, Src family tyrosine kinase antibody, Cellular Src antibody, p60c-Src antibody, pp60c-Src antibody, c-Src kinase antibody, SRC proto-oncogene antibody, Src signaling protein antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.